Leaderboard

En | De
Sie sind hier: Hämatologie » Neoplasie 18. April 2025
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Anämie
Gerinnungsstörungen
Neoplasie
Anderes
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 7893  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 157856  
   
Prevalence of medical writing in hematological malignancy review articles.
BMC Cancer
Vaquera-Alfaro HA, Nasrollahi E, Mangala YO, Russler-Germain D, Goodman A, Mohyuddin GR.
PMID: 40247240 [PubMed - indexed for MEDLINE]


CD5 and p53 immunohistochemistry: valuable prediction method in molecular typing of CD5-positive diffuse large B-cell lymphoma.
BMC Cancer
Wang H, Pan H, Zhang L, Luo D, Fan J, Li Q, Li X, Liu T, Shi L, Gao B, Chang X, Nie X.
PMID: 40247210 [PubMed - indexed for MEDLINE]


Polycythaemia vera.
Nat Rev Dis Primers
Harrison CN, Barbui T, Bose P, Kiladjian JJ, Mascarenhas J, McMullin MF, Mesa R, Vannucchi AM.
PMID: 40246933 [PubMed - indexed for MEDLINE]


Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients.
Blood Cancer J
Willekens C, Bazinet A, Chraibi S, Bataller A, Decroocq J, Arani N, Carpentier B, Rausch C, Lebon D, Maiti A, Gauthier N, Short N, Bonnet S, Sasaki K, Khalife-Hachem S, Swaminathan M, Micol JB, Pasquier F, Marzac C, Roos-Weil D, Pascal L, Daver N, Kadia T, Bouscary D, Ravandi F, Pages A, Kantarjian H, De Botton S, DiNardo C.
PMID: 40246832 [PubMed - indexed for MEDLINE]


Long-term outcomes and clinical phenotypes associated with best response to low dose alemtuzumab in cutaneous T-cell lymphoma.
Blood Cancer J
Larocca C, Bui AN, O'Malley JT, Giobbie-Hurder A, Tawa M, Teague JE, Clark RA, Cutler C, Jacobsen E, Fisher DC, Kupper TS, LeBoeuf NR.
PMID: 40246811 [PubMed - indexed for MEDLINE]


Semiquantitative PET Parameters Refine Prognosis in CAR T-Treated Lymphoma After 1 and 3 Months: A Prospective Single-Center Study.
J Nucl Med
Farolfi A, Casadei B, Malizia C, Ussia R, Rocchi V, Paccagnella A, Gentilini M, Nanni C, Argnani L, Zinzani PL, Fanti S.
PMID: 40246539 [PubMed - as supplied by publisher]


Severe Aortic Stenosis and Chronic Myeloid Leukemia: Considerations for Valve Management.
JACC CardioOncol
Cunningham R, Yoo SGK, Brescia AA, Oetjen KA, Pusic I, Mitchell JD.
PMID: 40246391 [PubMed]


Epiglottitis in Patients Treated for Acute Leukemia - Case Series and Systematic Review of the Literature.
Acta Haematol
Sherban A, Frisch A, Rozental A, Buchrits S, Atamna B, Ben-Ner D, Eden S, Atamna A, Ofran Y, Raanani P, Wolach O.
PMID: 40245848 [PubMed - as supplied by publisher]


Real-world (RW) study of outcomes for acute myeloid leukemia (AML) patients treated with glasdegib or venetoclax in US community oncology practices.
Expert Rev Hematol
Savill KMZ, Kish JK, Lee CH, Pathak P, D'Amico P, Russell-Smith A, Gajra A.
PMID: 40245377 [PubMed - as supplied by publisher]


Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial.
JAMA Oncol
Zhang M, Fu S, Feng J, Hong R, Wei G, Zhao H, Zhao M, Xu H, Cui J, Huang S, Wu X, Liu L, Sun J, Wu W, Zhu Y, He J, Zhao Y, Cai Z, Zheng W, Ye X, Shi J, Luo Y, Wang D, Chang AH, Hu Y, Huang H.
PMID: 40244598 [PubMed - as supplied by publisher]


Double Strike in Chronic Lymphocytic Leukemia-The Combination of BTK and BCL2 Inhibitors in Actual and Future Clinical Practice.
Int J Mol Sci
Zygmunciak P, Dancewicz H, Stró, B, Bieli, Robak T, Pu.
PMID: 40243993 [PubMed - indexed for MEDLINE]


Endoplasmic Reticulum Stress in Acute Myeloid Leukemia: Pathogenesis, Prognostic Implications, and Therapeutic Strategies.
Int J Mol Sci
Wiese W, Galita G, Siwecka N, Rozp, Slupianek A, Majsterek I.
PMID: 40243748 [PubMed - indexed for MEDLINE]


Assessment of a Systematic Screening of Occupational Exposures in Malignant Hemopathies in the Rhone-Alpes Area: Prolymphome Study.
Med Lav
Pérol O, Remion R, Charbotel B, Fervers B.
PMID: 40243547 [PubMed - indexed for MEDLINE]


Machine Learning-Based Prediction of Unplanned Readmission Due to Major Adverse Cardiac Events Among Hospitalized Patients with Blood Cancers.
Cancer Control
Le N, Han S, Kenawy AS, Kim Y, Park C.
PMID: 40243279 [PubMed - indexed for MEDLINE]


The cytoskeletal control of B cell receptor and integrin signaling in normal B cells and chronic lymphocytic leukemia.
FEBS Lett
Pethe A, Hartmann TN.
PMID: 40243025 [PubMed - as supplied by publisher]


Prognostic impact of fever at presentation in acute myeloid leukemia: a retrospective cohort study.
Leuk Lymphoma
Levanon E, Peles I, Meyer E, Tarab E, Giterman I, Sherf Y, Greenbaum U, Porges T.
PMID: 40242857 [PubMed - as supplied by publisher]


Outcomes and treatment patterns in primary and secondary plasma cell leukemia: insights from a large US cohort study.
Haematologica
Singh S, Peshin S, Wertheim BC, Larsen A, Chineke I, Sborov DW, Green D, Liedtke M, Okoniewski M, Wazir M, Nadeem O, Schachter LG, DeGraaff D, Vardell VA, Coffey DG, Gowin K.
PMID: 40241568 [PubMed - as supplied by publisher]


A phase II study of ponatinib for prevention of relapse after allotransplantation in FLT3 internal tandem duplication mutation positive (FLT3-ITD+) acute myeloid leukemia: the PONALLO trial.
Haematologica
Chevallier P, Thiebaut A, François S, Chantepie S, Rubio MT, Labussiere-Wallet H, Brissot E, Maillard N, Huynh A, Coiteux V, Jullien M, Garnier A, Le Bourgeois A, Peterlin P, Guillaume T.
PMID: 40241541 [PubMed - as supplied by publisher]


AI-assisted SERS imaging method for label-free and rapid discrimination of clinical lymphoma.
J Nanobiotechnology
Cao H, Wu X, Shi H, Chu B, He Y, Wang H, Dong F.
PMID: 40241186 [PubMed - indexed for MEDLINE]


Impact of lenalidomide consolidation on health-related quality of life in chronic lymphocytic leukemia: ancillary study of the phase III CLL6-RESIDUUM trial.
BMC Cancer
Wasse SK, Dabakuyo-Yonli ST, Gottlieb D, Cymbalista F, Mulligan S, Maynadie M, Aurran-Schleinitz T.
PMID: 40240989 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 157856    Seite 1 von 7893  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1